Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes

Jacob George, Muhammad Hussain, Thenmalar Vadiveloo, Sheila Ireland, Pippa Hopkinson, Allan D Struthers, Peter T Donnan, Faisel Khan, Chim C Lang, Jacob George, Muhammad Hussain, Thenmalar Vadiveloo, Sheila Ireland, Pippa Hopkinson, Allan D Struthers, Peter T Donnan, Faisel Khan, Chim C Lang

Abstract

Background: E-cigarette (EC) use is increasing exponentially worldwide. The early cardiovascular effects of switching from tobacco cigarettes (TC) to EC in chronic smokers is unknown. Meta-analysis of flow-mediated dilation (FMD) studies indicate 13% lower pooled, adjusted relative risks of cardiovascular events with every 1% improvement in FMD.

Objectives: This study sought to determine the early vascular impact of switching from TC to EC in chronic smokers.

Methods: The authors conducted a prospective, randomized control trial with a parallel nonrandomized preference cohort and blinded endpoint of smokers ≥18 years of age who had smoked ≥15 cigarettes/day for ≥2 years and were free from established cardiovascular disease. Participants were randomized to EC with nicotine or EC without nicotine for 1 month. Those unwilling to quit continued with TC in a parallel preference arm. A propensity score analysis was done to adjust for differences between the randomized and preference arms. Vascular function was assessed by FMD and pulse wave velocity. Compliance with EC was measured by carbon monoxide levels.

Results: Within 1 month of switching from TC to EC, there was a significant improvement in endothelial function (linear trend β = 0.73%; 95% confidence interval [CI]: 0.41 to 1.05; p < 0.0001; TC vs. EC combined: 1.49%; 95% CI: 0.93 to 2.04; p < 0.0001) and vascular stiffness (-0.529 m/s; 95% CI: -0.946 to -0.112; p = 0.014). Females benefited from switching more than males did in every between-group comparison. Those who complied best with EC switch demonstrated the largest improvement. There was no difference in vascular effects between EC with and without nicotine within the study timeframe.

Conclusions: TC smokers, particularly females, demonstrate significant improvement in vascular health within 1 month of switching from TC to EC. Switching from TC to EC may be considered a harms reduction measure. (Vascular Effects of Regular Cigarettes Versus Electronic Cigarette Use [VESUVIUS]; NCT02878421; ISRCTN59133298).

Keywords: electronic cigarette; endothelial function; vascular stiffness.

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Figures

Graphical abstract
Graphical abstract
Figure 1
Figure 1
CONSORT Diagram Flow chart showing patient involvement in the study. CONSORT = Consolidated Standards of Reporting Trials; EC = electronic cigarettes; FMD = flow-mediated dilation; TC = tobacco cigarettes.
Central Illustration
Central Illustration
Change in Mean Flow-Mediated Dilation Among Tobacco Cigarettes and Electronic Cigarettes With and Without Nicotine Adjusted mean percentage change in forearm flow-mediated dilation with 95% confidence intervals for subjects on electronic cigarettes (EC), EC-nicotine, and EC-nicotine-free.

References

    1. Ernst & Young . Ernst & Young; London, UK: 2017. Electronic Nicotine Delivery Systems (ENDS): An Update on a Rapidly Evolving Vapour Market. Report 2. 1–25.
    1. Mirbolouk M., Charkhchi P., Kianoush S. Prevalence and distribution of e-cigarette use among U.S. adults: behavioral risk factor surveillance system, 2016. Ann Intern Med. 2018;169:429–438.
    1. Ernst & Young . Ernst & Young; London, UK: 2016. E-Cigarettes: An Emerging Category. 1–19.
    1. Alzahrani T., Pena I., Temesgen N., Glantz S.A. Association between electronic cigarette use and myocardial infarction. Am J Prev Med. 2018;55:455–461.
    1. E-cigarettes: Public Health England's evidence-based confusion. Lancet. 2015;386:829.
    1. McKee M., Capewell S. Evidence about electronic cigarettes: a foundation built on rock or sand? BMJ. 2015;351:h4863.
    1. Csordas A., Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 2013;10:219–230.
    1. Farsalinos K.E., Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5:67–86.
    1. Lisko J.G., Tran H., Stanfill S.B., Blount B.C., Watson C.H. Chemical composition and evaluation of nicotine, tobacco alkaloids, pH, and selected flavors in E-cigarette cartridges and refill solutions. Nicotine Tob Res. 2015;17:1270–1278.
    1. Heeschen C., Jang J.J., Weis M. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001;7:833–839.
    1. Benowitz N.L., Burbank A.D. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc Med. 2016;26:515–523.
    1. Inaba Y., Chen J.A., Bergmann S.R. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging. 2010;26:631–640.
    1. Ras R.T., Streppel M.T., Draijer R., Zock P.L. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol. 2013;168:344–351.
    1. Willum-Hansen T., Staessen J.A., Torp-Pedersen C. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113:664–670.
    1. Thijssen D.H.J., Black M.A., Pyke K.E. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011;300:H2–H12.
    1. Hajek P., Phillips-Waller A., Przulj D. A randomized trial of E-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380:629–637.
    1. Yan X.S., D'Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol. 2015;71:24–34.
    1. Khan F., Ray S., Craigie A.M. Lowering of oxidative stress improves endothelial function in healthy subjects with habitually low intake of fruit and vegetables: a randomized controlled trial of antioxidant- and polyphenol-rich blackcurrant juice. Free Radic Biol Med. 2014;72:232–237.
    1. Corretti M.C., Anderson T.J., Benjamin E.J. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–265.
    1. Benowitz N.L., Fraiman J.B. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol. 2017;14:447–456.
    1. Risch H.A., Howe G.R., Jain M., Burch J.D., Holowaty E.J., Miller A.B. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol. 1993;138:281–293.
    1. Prescott E., Hippe M., Schnohr P., Hein H.O., Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998;316:1043.
    1. Vaidya V., Gangal N.S., Shah S., Gangan N., Bechtol R. Trends in smoking status and utilization of smoking cessation agents among females with cardiovascular diseases. J Womens Health (Larchmt) 2016;25:270–275.
    1. WHO . Department of Gender, Women and Health, World Health Organization; Geneva, Switzerland: 2010. 10 Facts on Gender and Tobacco.
    1. Robertson L., Hoek J., Blank M.L., Richards R., Ling P., Popova L. Dual use of electronic nicotine delivery systems (ENDS) and smoked tobacco: a qualitative analysis. Tob Control. 2019;28:13–19.
    1. Tadic M., Cuspidi C., Grassi G. Heart rate as a predictor of cardiovascular risk. Eur J Clin Invest. 2018;48
    1. Zhang D., Shen X., Qi X. Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ. 2016;188:E53–E63.
    1. Bolinder G., de Faire U. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am J Hypertens. 1998;11:1153–1163.
    1. Carnevale R., Sciarretta S., Violi F. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest. 2016;150:606–612.
    1. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673–2678.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit